Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients
by on Friday, December 9th, 2011 | No Comments
Condition: Hepatocellular,Carcinoma
Interventions: Drug: Tyroserleutide injection, mitomycin, and Fluorouracil (chemotherapy); Drug: Placebo
Sponsors: Shenzhen Kangzhe Pharmaceutical Co., Ltd.; Fudan University; Peking University; Medpace, Inc.
Recruiting – verified December 2011
Read the original: Study of Tyroserleutide for Injection in Hepatocellular Carcinoma (HCC) Patients